BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/64/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 13:53:29 2024-06-14 EDT | ||
| 0.016 EUR | -20.00% |
|
| Current month | -46.67% | ||
| 1 month | -65.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 0.016 | -20.00% |
| 24-06-13 | 0.02 | -16.67% |
| 24-06-12 | 0.024 | -11.11% |
| 24-06-11 | 0.027 | +50.00% |
| 24-06-10 | 0.018 | -25.00% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 01:53 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM7PAH |
| ISIN | DE000VM7PAH6 |
| Date issued | 2023-12-29 |
| Strike | 64 $ |
| Maturity | 2024-09-20 (97 Days) |
| Parity | 10 : 1 |
| Emission price | 0.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.36 € |
|---|---|
| Lowest since issue | 0.009 € |
| Spread | 0.01 € |
| Spread % | 35.71% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.29
USD
Average target price
96.24
USD
Spread / Average Target
+10.25%
- Stock Market
- Warrants
- Warrant
